Helicobacter Pylori and Endoscopy: Diagnosis and Eradication
Helicobacter pylori and endoscopy: diagnosis, biopsies, and eradication protocol
Colombia has one of the highest H. pylori prevalences in the world — endoscopy with biopsies is the diagnostic gold standard and the only method that also identifies associated gastric lesions. Complete 2026 guide
Colombia has a Helicobacter pylori prevalence of 65–70% in the adult population — one of the highest in Latin America — and this bacterium is the most important type I carcinogen for gastric cancer. Endoscopy with biopsies is the only method that simultaneously diagnoses the infection, evaluates gastric mucosal damage (atrophic gastritis, intestinal metaplasia) and obtains tissue for histology — information that no non-invasive test can provide.
1. Why Colombia has such a high H. pylori prevalence
2. How H. pylori is diagnosed in endoscopy
3. LCI and NBI for H. pylori — enhanced imaging changes the diagnosis
4. First-line eradication in Colombia 2026
| Regimen | Drugs | Duration | Eradication rate Colombia |
|---|---|---|---|
| Bismuth quadruple therapy (recommended 1st line) | PPI + bismuth + metronidazole + tetracycline | 10–14 days | 85–90% — superior to triple therapy with clarithromycin |
| PPI + amoxicillin + clarithromycin + metronidazole | 10–14 days | 80–88% — valid if clarithromycin resistance <15% | |
| PPI + amoxicillin + clarithromycin | 14 days | 65–75% — increasingly less effective due to growing resistances in Colombia |
Related articles
Sources
- SCG. H. pylori Colombia Clinical Practice Guideline. gastrocol.com. 2024. Prevalence, regimens. Colombia SCG 2024
- Malfertheiner P et al. Kyoto Global Consensus — H. pylori. Gut. 2022. Kyoto 2022
- Ono S et al. LCI for H. pylori detection. J Gastroenterol. 2022. LCI sensitivity 87%. Ono 2022
- INC Colombia. Atlas of gastric cancer mortality. cancer.gov.co. 2025. Colombia

